Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Aristidis Veves, D.Sc., M.D.

TitleProfessor of Surgery
InstitutionBeth Israel Deaconess Medical Center
DepartmentSurgery
AddressBeth Israel Deaconess Med Ctr
321A Palmer Bldg - West Campus
One Deaconess Rd
Boston MA 02215
Phone617/632-7075
Fax617/632-7090

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Tecilazich F, Dinh T, Pradhan-Nabzdyk L, Leal E, Tellechea A, Kafanas A, Gnardellis C, Magargee ML, Dejam A, Toxavidis V, Tigges JC, Carvalho E, Lyons TE, Veves A. Role of endothelial progenitor cells and inflammatory cytokines in healing of diabetic foot ulcers. PLoS One. 2013; 8(12):e83314.
    View in: PubMed
  2. Veves A, Baltzis D, Eleftheriadou I. Diabetes treatment: recent developments. Adv Ther. 2013 Dec; 30(12):1031-2.
    View in: PubMed
  3. Bakker JP, Balachandran JS, Tecilazich F, Deyoung PN, Smales E, Veves A, Malhotra A. Pilot study of the effects of bariatric surgery and continuous positive airway pressure treatment on vascular function in obese subjects with obstructive sleep apnoea. Intern Med J. 2013 Sep; 43(9):993-8.
    View in: PubMed
  4. Carter SG, Zhu Z, Varadi G, Veves A, Riviere JE. Vasomodulation influences on the transdermal delivery of Ibuprofen. J Pharm Sci. 2013 Nov; 102(11):4072-8.
    View in: PubMed
  5. Kaczmarek E, Bakker JP, Clarke DN, Csizmadia E, Kocher O, Veves A, Tecilazich F, O'Donnell CP, Ferran C, Malhotra A. Molecular biomarkers of vascular dysfunction in obstructive sleep apnea. PLoS One. 2013; 8(7):e70559.
    View in: PubMed
  6. Pradhan Nabzdyk L, Kuchibhotla S, Guthrie P, Chun M, Auster ME, Nabzdyk C, Deso S, Andersen N, Gnardellis C, Logerfo FW, Veves A. Expression of neuropeptides and cytokines in a rabbit model of diabetic neuroischemic wound healing. J Vasc Surg. 2013 Sep; 58(3):766-775.e12.
    View in: PubMed
  7. Gibbons CH, Freeman R, Tecilazich F, Dinh T, Lyons TE, Gnardellis C, Veves A. The evolving natural history of neurophysiologic function in patients with well-controlled diabetes. J Peripher Nerv Syst. 2013 Jun; 18(2):153-61.
    View in: PubMed
  8. Tecilazich F, Dinh TL, Veves A. Emerging drugs for the treatment of diabetic ulcers. Expert Opin Emerg Drugs. 2013 Jun; 18(2):207-17.
    View in: PubMed
  9. Tecilazich F, Dinh T, Lyons TE, Guest J, Villafuerte RA, Sampanis C, Gnardellis C, Zuo CS, Veves A. Postexercise phosphocreatine recovery, an index of mitochondrial oxidative phosphorylation, is reduced in diabetic patients with lower extremity complications. J Vasc Surg. 2013 Apr; 57(4):997-1005.
    View in: PubMed
  10. Tellechea A, Kafanas A, Leal EC, Tecilazich F, Kuchibhotla S, Auster ME, Kontoes I, Paolino J, Carvalho E, Nabzdyk LP, Veves A. Increased skin inflammation and blood vessel density in human and experimental diabetes. Int J Low Extrem Wounds. 2013 Mar; 12(1):4-11.
    View in: PubMed
  11. Crawford F, Anandan C, Chappell FM, Murray GD, Price JF, Sheikh A, Simpson CR, Maxwell M, Stansby GP, Young MJ, Abbott CA, Boulton AJ, Boyko EJ, Kastenbauer T, Leese GP, Monami M, Monteiro-Soares M, Rith-Najarian SJ, Veves A, Coates N, Jeffcoate WJ, Leech N, Fahey T, Tierney J. Protocol for a systematic review and individual patient data meta-analysis of prognostic factors of foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS). BMC Med Res Methodol. 2013; 13:22.
    View in: PubMed
  12. Dinh T, Tecilazich F, Kafanas A, Doupis J, Gnardellis C, Leal E, Tellechea A, Pradhan L, Lyons TE, Giurini JM, Veves A. Mechanisms involved in the development and healing of diabetic foot ulceration. Diabetes. 2012 Nov; 61(11):2937-47.
    View in: PubMed
  13. Tecilazich F, Dinh T, Veves A. Treating diabetic ulcers. Expert Opin Pharmacother. 2011 Mar; 12(4):593-606.
    View in: PubMed
  14. Veves A. Discussion. Bioengineered skin constructs and their use in wound healing. Plast Reconstr Surg. 2011 Jan; 127 Suppl 1:91S-92S.
    View in: PubMed
  15. Rajesh M, Mukhopadhyay P, Bátkai S, Patel V, Saito K, Matsumoto S, Kashiwaya Y, Horváth B, Mukhopadhyay B, Becker L, Haskó G, Liaudet L, Wink DA, Veves A, Mechoulam R, Pacher P. Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy. J Am Coll Cardiol. 2010 Dec 14; 56(25):2115-25.
    View in: PubMed
  16. Shrikhande GV, Scali ST, da Silva CG, Damrauer SM, Csizmadia E, Putheti P, Matthey M, Arjoon R, Patel R, Siracuse JJ, Maccariello ER, Andersen ND, Monahan T, Peterson C, Essayagh S, Studer P, Guedes RP, Kocher O, Usheva A, Veves A, Kaczmarek E, Ferran C. O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice. PLoS One. 2010; 5(12):e14240.
    View in: PubMed
  17. Doupis J, Rahangdale S, Gnardellis C, Pena SE, Malhotra A, Veves A. Effects of diabetes and obesity on vascular reactivity, inflammatory cytokines, and growth factors. Obesity (Silver Spring). 2011 Apr; 19(4):729-35.
    View in: PubMed
  18. Yim-Yeh S, Rahangdale S, Nguyen AT, Jordan AS, Novack V, Veves A, Malhotra A. Obstructive sleep apnea and aging effects on macrovascular and microcirculatory function. Sleep. 2010 Sep; 33(9):1177-83.
    View in: PubMed
  19. Gibbons CH, Freeman R, Veves A. Diabetic neuropathy: a cross-sectional study of the relationships among tests of neurophysiology. Diabetes Care. 2010 Dec; 33(12):2629-34.
    View in: PubMed
  20. Yim-Yeh S, Rahangdale S, Nguyen AT, Stevenson KE, Novack V, Veves A, Malhotra A. Vascular dysfunction in obstructive sleep apnea and type 2 diabetes mellitus. Obesity (Silver Spring). 2011 Jan; 19(1):17-22.
    View in: PubMed
  21. Chin MS, Ogawa R, Lancerotto L, Pietramaggiori G, Schomacker KT, Mathews JC, Scherer SS, Van Duyn P, Prsa MJ, Ottensmeyer MP, Veves A, Orgill DP. In vivo acceleration of skin growth using a servo-controlled stretching device. Tissue Eng Part C Methods. 2010 Jun; 16(3):397-405.
    View in: PubMed
  22. Dinh T, Snyder G, Veves A. Current techniques to detect foot infection in the diabetic patient. Int J Low Extrem Wounds. 2010 Mar; 9(1):24-30.
    View in: PubMed
  23. Kasselman LJ, Veves A, Gibbons CH, Rutkove SB. Cold exposure exacerbates the development of diabetic polyneuropathy in the rat. Exp Diabetes Res. 2009; 2009:827943.
    View in: PubMed
  24. Pradhan L, Cai X, Wu S, Andersen ND, Martin M, Malek J, Guthrie P, Veves A, Logerfo FW. Gene expression of pro-inflammatory cytokines and neuropeptides in diabetic wound healing. J Surg Res. 2011 May 15; 167(2):336-42.
    View in: PubMed
  25. Dinh T, Doupis J, Lyons TE, Kuchibhotla S, Julliard W, Gnardellis C, Rosenblum BI, Wang X, Giurini JM, Greenman RL, Veves A. Foot muscle energy reserves in diabetic patients without and with clinical peripheral neuropathy. Diabetes Care. 2009 Aug; 32(8):1521-4.
    View in: PubMed
  26. Dinh T, Scovell S, Veves A. Peripheral arterial disease and diabetes: a clinical update. Int J Low Extrem Wounds. 2009 Jun; 8(2):75-81.
    View in: PubMed
  27. Khaodhiar L, Brennan AM, Lima C, Chan JL, Mantzoros CS, Manning WJ, Danias PG, Veves A. Effect of valsartan on left ventricular anatomy and systolic function and aortic elasticity. Metabolism. 2009 May; 58(5):682-8.
    View in: PubMed
  28. Yeh SY, Doupis J, Rahangdale S, Horr S, Malhotra A, Veves A. Total serum bilirubin does not affect vascular reactivity in patients with diabetes. Vasc Med. 2009 May; 14(2):129-36.
    View in: PubMed
  29. Doupis J, Lyons TE, Wu S, Gnardellis C, Dinh T, Veves A. Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy. J Clin Endocrinol Metab. 2009 Jun; 94(6):2157-63.
    View in: PubMed
  30. Rutkove SB, Veves A, Mitsa T, Nie R, Fogerson PM, Garmirian LP, Nardin RA. Impaired distal thermoregulation in diabetes and diabetic polyneuropathy. Diabetes Care. 2009 Apr; 32(4):671-6.
    View in: PubMed
  31. Pradhan L, Nabzdyk C, Andersen ND, LoGerfo FW, Veves A. Inflammation and neuropeptides: the connection in diabetic wound healing. Expert Rev Mol Med. 2009; 11:e2.
    View in: PubMed
  32. Cloutier R, Horr S, Niemi JB, D'Andrea S, Lima C, Harry JD, Veves A. Prolonged mechanical noise restores tactile sense in diabetic neuropathic patients. Int J Low Extrem Wounds. 2009 Mar; 8(1):6-10.
    View in: PubMed
  33. Rahangdale S, Yeh SY, Malhotra A, Veves A. Therapeutic interventions and oxidative stress in diabetes. Front Biosci. 2009; 14:192-209.
    View in: PubMed
  34. Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 2008 Sep; 9(6):660-74.
    View in: PubMed
  35. Dinh T, Veves A. Evidence-based medicine and the management of the chronic wound: is it enough? Int J Low Extrem Wounds. 2008 Sep; 7(3):118-9.
    View in: PubMed
  36. Doupis J, Veves A. DPP4 inhibitors: a new approach in diabetes treatment. Adv Ther. 2008 Jul; 25(7):627-43.
    View in: PubMed
  37. Steed DL, Attinger C, Brem H, Colaizzi T, Crossland M, Franz M, Harkless L, Johnson A, Moosa H, Robson M, Serena T, Sheehan P, Veves A, Wiersma-Bryant L. Guidelines for the prevention of diabetic ulcers. Wound Repair Regen. 2008 Mar-Apr; 16(2):169-74.
    View in: PubMed
  38. Khaodhiar L, Dinh T, Schomacker KT, Panasyuk SV, Freeman JE, Lew R, Vo T, Panasyuk AA, Lima C, Giurini JM, Lyons TE, Veves A. The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes. Diabetes Care. 2007 Apr; 30(4):903-10.
    View in: PubMed
  39. Yim S, Malhotra A, Veves A. Antioxidants and CVD in diabetes: where do we stand now. Curr Diab Rep. 2007 Feb; 7(1):8-13.
    View in: PubMed
  40. Lyons TE, Miller MS, Serena T, Sheehan P, Lavery L, Kirsner RS, Armstrong DG, Reese A, Yankee EW, Veves A. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study. Am J Surg. 2007 Jan; 193(1):49-54.
    View in: PubMed
  41. O'Neill MS, Veves A, Sarnat JA, Zanobetti A, Gold DR, Economides PA, Horton ES, Schwartz J. Air pollution and inflammation in type 2 diabetes: a mechanism for susceptibility. Occup Environ Med. 2007 Jun; 64(6):373-9.
    View in: PubMed
  42. Dinh TL, Veves A. Treatment of diabetic ulcers. Dermatol Ther. 2006 Nov-Dec; 19(6):348-55.
    View in: PubMed
  43. Steed DL, Attinger C, Colaizzi T, Crossland M, Franz M, Harkless L, Johnson A, Moosa H, Robson M, Serena T, Sheehan P, Veves A, Wiersma-Bryant L. Guidelines for the treatment of diabetic ulcers. Wound Repair Regen. 2006 Nov-Dec; 14(6):680-92.
    View in: PubMed
  44. Schramm JC, Dinh T, Veves A. Microvascular changes in the diabetic foot. Int J Low Extrem Wounds. 2006 Sep; 5(3):149-59.
    View in: PubMed
  45. Malik RA, Veves A, Tesfaye S. Ameliorating human diabetic neuropathy: lessons from implanting hematopoietic mononuclear cells. Exp Neurol. 2006 Sep; 201(1):7-14.
    View in: PubMed
  46. Dinh TL, Veves A. The efficacy of Apligraf in the treatment of diabetic foot ulcers. Plast Reconstr Surg. 2006 Jun; 117(7 Suppl):152S-157S; discussion 158S-159S.
    View in: PubMed
  47. Sheehan P, Jones P, Giurini JM, Caselli A, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Plast Reconstr Surg. 2006 Jun; 117(7 Suppl):239S-244S.
    View in: PubMed
  48. Caselli A, Spallone V, Marfia GA, Battista C, Pachatz C, Veves A, Uccioli L. Validation of the nerve axon reflex for the assessment of small nerve fibre dysfunction. J Neurol Neurosurg Psychiatry. 2006 Aug; 77(8):927-32.
    View in: PubMed
  49. Shrikhande G, Khaodhiar L, Scali S, Lima C, Hubbard M, Dudley K, Ganda O, Ferran C, Veves A. Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. J Vasc Surg. 2006 Apr; 43(4):760-70; discussion 770-1.
    View in: PubMed
  50. Priplata AA, Patritti BL, Niemi JB, Hughes R, Gravelle DC, Lipsitz LA, Veves A, Stein J, Bonato P, Collins JJ. Noise-enhanced balance control in patients with diabetes and patients with stroke. Ann Neurol. 2006 Jan; 59(1):4-12.
    View in: PubMed
  51. Greenman RL, Panasyuk S, Wang X, Lyons TE, Dinh T, Longoria L, Giurini JM, Freeman J, Khaodhiar L, Veves A. Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet. 2005 Nov 12; 366(9498):1711-7.
    View in: PubMed
  52. Dinh TL, Veves A. A review of the mechanisms implicated in the pathogenesis of the diabetic foot. Int J Low Extrem Wounds. 2005 Sep; 4(3):154-9.
    View in: PubMed
  53. Skljarevski V, Veves A. Impact of diabetes on vasculature: focus on nervous system. Curr Diabetes Rev. 2005 Aug; 1(3):245-53.
    View in: PubMed
  54. Buras J, Reenstra WR, Orlow D, Horton ES, Veves A. Troglitazone-induced changes in adiponectin do not affect endothelial function in diabetes. Obes Res. 2005 Jul; 13(7):1167-74.
    View in: PubMed
  55. Greenman RL, Khaodhiar L, Lima C, Dinh T, Giurini JM, Veves A. Foot small muscle atrophy is present before the detection of clinical neuropathy. Diabetes Care. 2005 Jun; 28(6):1425-30.
    View in: PubMed
  56. O'Neill MS, Veves A, Zanobetti A, Sarnat JA, Gold DR, Economides PA, Horton ES, Schwartz J. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation. 2005 Jun 7; 111(22):2913-20.
    View in: PubMed
  57. Dinh T, Veves A. Microcirculation of the diabetic foot. Curr Pharm Des. 2005; 11(18):2301-9.
    View in: PubMed
  58. Economides PA, Khaodhiar L, Caselli A, Caballero AE, Keenan H, Bursell SE, King GL, Johnstone MT, Horton ES, Veves A. The effect of vitamin E on endothelial function of micro- and macrocirculation and left ventricular function in type 1 and type 2 diabetic patients. Diabetes. 2005 Jan; 54(1):204-11.
    View in: PubMed
  59. Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care. 2004 Oct; 27(10):2450-7.
    View in: PubMed
  60. Dinh TL, Veves A. Microcirculation in the diabetic foot: an update. Int J Low Extrem Wounds. 2004 Jun; 3(2):60-1.
    View in: PubMed
  61. Viswanathan V, Sivagami M, Seena R, Snehalatha C, Ramachandran A, Veves A. Increased forefoot to rearfoot plantar pressure ratio in South Indian patients with diabetic foot ulceration. Diabet Med. 2004 Apr; 21(4):396-7.
    View in: PubMed
  62. Economides PA, Caselli A, Zuo CS, Sparks C, Khaodhiar L, Katsilambros N, Horton ES, Veves A. Kidney oxygenation during water diuresis and endothelial function in patients with type 2 diabetes and subjects at risk to develop diabetes. Metabolism. 2004 Feb; 53(2):222-7.
    View in: PubMed
  63. Economides PA, Caselli A, Tiani E, Khaodhiar L, Horton ES, Veves A. The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes. J Clin Endocrinol Metab. 2004 Feb; 89(2):740-7.
    View in: PubMed
  64. Hile C, Veves A. Diabetic neuropathy and microcirculation. Curr Diab Rep. 2003 Dec; 3(6):446-51.
    View in: PubMed
  65. Khaodhiar L, Niemi JB, Earnest R, Lima C, Harry JD, Veves A. Enhancing sensation in diabetic neuropathic foot with mechanical noise. Diabetes Care. 2003 Dec; 26(12):3280-3.
    View in: PubMed
  66. Caselli A, Uccioli L, Khaodhiar L, Veves A. Local anesthesia reduces the maximal skin vasodilation during iontophoresis of sodium nitroprusside and heating. Microvasc Res. 2003 Sep; 66(2):134-9.
    View in: PubMed
  67. Caselli A, Hanane T, Jane B, Carter S, Khaodhiar L, Veves A. Topical methyl nicotinate-induced skin vasodilation in diabetic neuropathy. J Diabetes Complications. 2003 Jul-Aug; 17(4):205-10.
    View in: PubMed
  68. Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Caselli A, Caballero AE, Economides PA, Veves A, Horton ES. Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care. 2003 Jul; 26(7):2119-25.
    View in: PubMed
  69. Sheehan P, Jones P, Caselli A, Giurini JM, Veves A. Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care. 2003 Jun; 26(6):1879-82.
    View in: PubMed
  70. Varo N, Vicent D, Libby P, Nuzzo R, Calle-Pascual AL, Bernal MR, Fernández-Cruz A, Veves A, Jarolim P, Varo JJ, Goldfine A, Horton E, Schönbeck U. Elevated plasma levels of the atherogenic mediator soluble CD40 ligand in diabetic patients: a novel target of thiazolidinediones. Circulation. 2003 Jun 3; 107(21):2664-9.
    View in: PubMed
  71. Khaodhiar L, Veves A. Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes. Diabetes Care. 2003 Mar; 26(3):962-3; author reply 963.
    View in: PubMed
  72. Caballero AE, Saouaf R, Lim SC, Hamdy O, Abou-Elenin K, O'Connor C, Logerfo FW, Horton ES, Veves A. The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial. Metabolism. 2003 Feb; 52(2):173-80.
    View in: PubMed
  73. Caselli A, Rich J, Hanane T, Uccioli L, Veves A. Role of C-nociceptive fibers in the nerve axon reflex-related vasodilation in diabetes. Neurology. 2003 Jan 28; 60(2):297-300.
    View in: PubMed
  74. Szabó C, Zanchi A, Komjáti K, Pacher P, Krolewski AS, Quist WC, LoGerfo FW, Horton ES, Veves A. Poly(ADP-Ribose) polymerase is activated in subjects at risk of developing type 2 diabetes and is associated with impaired vascular reactivity. Circulation. 2002 Nov 19; 106(21):2680-6.
    View in: PubMed
  75. Veves A, Sheehan P, Pham HT. A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers. Arch Surg. 2002 Jul; 137(7):822-7.
    View in: PubMed
  76. Caselli A, Pham H, Giurini JM, Armstrong DG, Veves A. The forefoot-to-rearfoot plantar pressure ratio is increased in severe diabetic neuropathy and can predict foot ulceration. Diabetes Care. 2002 Jun; 25(6):1066-71.
    View in: PubMed
  77. Pham HT, Exelbert L, Segal-Owens AC, Veves A. A prospective, randomized, controlled double-blind study of a moisturizer for xerosis of the feet in patients with diabetes. Ostomy Wound Manage. 2002 May; 48(5):30-6.
    View in: PubMed
  78. Pham HT, Rich J, Veves A. Using living skin equivalents for diabetic foot ulceration. Int J Low Extrem Wounds. 2002 Mar; 1(1):27-32.
    View in: PubMed
  79. Arora S, Pomposelli F, LoGerfo FW, Veves A. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J Vasc Surg. 2002 Mar; 35(3):501-5.
    View in: PubMed
  80. Epstein FH, Veves A, Prasad PV. Effect of diabetes on renal medullary oxygenation during water diuresis. Diabetes Care. 2002 Mar; 25(3):575-8.
    View in: PubMed
  81. Abou-Elenin K, Xydakis A, Hamdy O, Economides PA, Horton ES, Veves A. The effect of aspirin and various iontophoresis solution vehicles on skin microvascular reactivity. Microvasc Res. 2002 Jan; 63(1):91-5.
    View in: PubMed
  82. Veves A, King GL. Can VEGF reverse diabetic neuropathy in human subjects? J Clin Invest. 2001 May; 107(10):1215-8.
    View in: PubMed
  83. Malik RA, Veves A, Walker D, Siddique I, Lye RH, Schady W, Boulton AJ. Sural nerve fibre pathology in diabetic patients with mild neuropathy: relationship to pain, quantitative sensory testing and peripheral nerve electrophysiology. Acta Neuropathol. 2001 Apr; 101(4):367-74.
    View in: PubMed
  84. Hamdy O, Abou-Elenin K, LoGerfo FW, Horton ES, Veves A. Contribution of nerve-axon reflex-related vasodilation to the total skin vasodilation in diabetic patients with and without neuropathy. Diabetes Care. 2001 Feb; 24(2):344-9.
    View in: PubMed
  85. Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care. 2001 Feb; 24(2):290-5.
    View in: PubMed
  86. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care. 2000 May; 23(5):606-11.
    View in: PubMed
  87. Lim SC, Caballero AE, Arora S, Smakowski P, Bashoff EM, Brown FM, Logerfo FW, Horton ES, Veves A. The effect of hormonal replacement therapy on the vascular reactivity and endothelial function of healthy individuals and individuals with type 2 diabetes. J Clin Endocrinol Metab. 1999 Nov; 84(11):4159-64.
    View in: PubMed
  88. Lim SC, Caballero AE, Smakowski P, LoGerfo FW, Horton ES, Veves A. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care. 1999 Nov; 22(11):1865-70.
    View in: PubMed
  89. Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES, Veves A. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes. 1999 Sep; 48(9):1856-62.
    View in: PubMed
  90. Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressures in diabetic foot ulceration. Diabetes Care. 1998 Oct; 21(10):1714-9.
    View in: PubMed
  91. Akbari CM, Saouaf R, Barnhill DF, Newman PA, LoGerfo FW, Veves A. Endothelium-dependent vasodilatation is impaired in both microcirculation and macrocirculation during acute hyperglycemia. J Vasc Surg. 1998 Oct; 28(4):687-94.
    View in: PubMed
  92. Saouaf R, Arora S, Smakowski P, Caballero AE, Veves A. Reactive hyperemic response of the brachial artery: comparison of proximal and distal occlusion. Acad Radiol. 1998 Aug; 5(8):556-60.
    View in: PubMed
  93. Arora S, Smakowski P, Frykberg RG, Simeone LR, Freeman R, LoGerfo FW, Veves A. Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy. Diabetes Care. 1998 Aug; 21(8):1339-44.
    View in: PubMed
  94. Arora S, Veves A, Caballaro AE, Smakowski P, LoGerfo FW. Estrogen improves endothelial function. J Vasc Surg. 1998 Jun; 27(6):1141-6; discussion 1147.
    View in: PubMed
  95. Donaghue VM, Chrzan JS, Rosenblum BI, Giurini JM, Habershaw GM, Veves A. Evaluation of a collagen-alginate wound dressing in the management of diabetic foot ulcers. Adv Wound Care. 1998 May-Jun; 11(3):114-9.
    View in: PubMed
  96. Veves A, Akbari CM, Primavera J, Donaghue VM, Zacharoulis D, Chrzan JS, DeGirolami U, LoGerfo FW, Freeman R. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease, and foot ulceration. Diabetes. 1998 Mar; 47(3):457-63.
    View in: PubMed
  97. Pham HT, Economides PA, Veves A. The role of endothelial function on the foot. Microcirculation and wound healing in patients with diabetes. Clin Podiatr Med Surg. 1998 Jan; 15(1):85-93.
    View in: PubMed
  98. Veves A, Saouaf R, Donaghue VM, Mullooly CA, Kistler JA, Giurini JM, Horton ES, Fielding RA. Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes. 1997 Nov; 46(11):1846-52.
    View in: PubMed
  99. Simeone LR, Veves A. Screening techniques to identify the diabetic patient at risk of ulceration. J Am Podiatr Med Assoc. 1997 Jul; 87(7):313-7.
    View in: PubMed
  100. Akbari CM, Gibbons GW, Habershaw GM, LoGerfo FW, Veves A. The effect of arterial reconstruction on the natural history of diabetic neuropathy. Arch Surg. 1997 Feb; 132(2):148-52.
    View in: PubMed
  101. Frykberg RG, Piaggesi A, Donaghue VM, Schipani E, Habershaw GM, Navalesi R, Veves A. Difference in treatment of foot ulcerations in Boston, USA and Pisa, Italy. Diabetes Res Clin Pract. 1997 Feb; 35(1):21-6.
    View in: PubMed
  102. Frykberg RG, Veves A. Diabetic foot infections. Diabetes Metab Rev. 1996 Oct; 12(3):255-70.
    View in: PubMed
  103. Young MJ, Bennett JL, Liderth SA, Veves A, Boulton AJ, Douglas JT. Rheological and microvascular parameters in diabetic peripheral neuropathy. Clin Sci (Lond). 1996 Mar; 90(3):183-7.
    View in: PubMed
  104. Veves A, Donaghue VM, Sarnow MR, Giurini JM, Campbell DR, LoGerfo FW. The impact of reversal of hypoxia by revascularization on the peripheral nerve function of diabetic patients. Diabetologia. 1996 Mar; 39(3):344-8.
    View in: PubMed
  105. Donaghue VM, Sarnow MR, Giurini JM, Chrzan JS, Habershaw GM, Veves A. Longitudinal in-shoe foot pressure relief achieved by specially designed footwear in high risk diabetic patients. Diabetes Res Clin Pract. 1996 Mar; 31(1-3):109-14.
    View in: PubMed
  106. Young MJ, Veves A, Smith JV, Walker MG, Boulton AJ. Restoring lower limb blood flow improves conduction velocity in diabetic patients. Diabetologia. 1995 Sep; 38(9):1051-4.
    View in: PubMed
  107. Donaghue VM, Giurini JM, Rosenblum BI, Weissman PN, Veves A. Variability in function measurements of three sensory foot nerves in neuropathic diabetic patients. Diabetes Res Clin Pract. 1995 Jul; 29(1):37-42.
    View in: PubMed
  108. Veves A, Sarnow MR, Giurini JM, Rosenblum BI, Lyons TE, Chrzan JS, Habershaw GM. Differences in joint mobility and foot pressures between black and white diabetic patients. Diabet Med. 1995 Jul; 12(7):585-9.
    View in: PubMed
  109. Veves A, Sarnow MR. Diagnosis, classification, and treatment of diabetic peripheral neuropathy. Clin Podiatr Med Surg. 1995 Jan; 12(1):19-30.
    View in: PubMed
  110. Veves A, Webster L, Chen TF, Payne S, Boulton AJ. Aetiopathogenesis and management of impotence in diabetic males: four years experience from a combined clinic. Diabet Med. 1995 Jan; 12(1):77-82.
    View in: PubMed
  111. Veves A, Young MJ, Manes C, Boulton AJ. Differences in peripheral and autonomic nerve function measurements in painful and painless neuropathy. A clinical study. Diabetes Care. 1994 Oct; 17(10):1200-2.
    View in: PubMed
  112. Malik RA, Tesfaye S, Thompson SD, Veves A, Hunter A, Sharma AK, Ward JD, Boulton AJ. Transperineurial capillary abnormalities in the sural nerve of patients with diabetic neuropathy. Microvasc Res. 1994 Sep; 48(2):236-45.
    View in: PubMed
  113. Sarnow MR, Veves A, Giurini JM, Rosenblum BI, Chrzan JS, Habershaw GM. In-shoe foot pressure measurements in diabetic patients with at-risk feet and in healthy subjects. Diabetes Care. 1994 Sep; 17(9):1002-6.
    View in: PubMed
  114. Veves A, Uccioli L, Manes C, Van Acker K, Komninou H, Philippides P, Katsilambros N, De Leeuw I, Menzinger G, Boulton AJ. Comparison of risk factors for foot problems in diabetic patients attending teaching hospital outpatient clinics in four different European states. Diabet Med. 1994 Aug-Sep; 11(7):709-13.
    View in: PubMed
  115. Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care. 1994 Jun; 17(6):557-60.
    View in: PubMed
  116. Murray HJ, Veves A, Young MJ, Richie DH, Boulton AJ. Role of experimental socks in the care of the high-risk diabetic foot. A multicenter patient evaluation study. American Group for the Study of Experimental Hosiery in the Diabetic Foot. Diabetes Care. 1993 Aug; 16(8):1190-2.
    View in: PubMed
  117. Veves A, Manes C, Murray HJ, Young MJ, Boulton AJ. Painful neuropathy and foot ulceration in diabetic patients. Diabetes Care. 1993 Aug; 16(8):1187-9.
    View in: PubMed
  118. Young MJ, Veves A, Boulton AJ. The diabetic foot: aetiopathogenesis and management. Diabetes Metab Rev. 1993 Jul; 9(2):109-27.
    View in: PubMed
  119. Veves A, Boulton AJ. The optical pedobarograph. Clin Podiatr Med Surg. 1993 Jul; 10(3):463-70.
    View in: PubMed
  120. Malik RA, Tesfaye S, Thompson SD, Veves A, Sharma AK, Boulton AJ, Ward JD. Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia. 1993 May; 36(5):454-9.
    View in: PubMed
  121. Veves A, Boulton AJ. An optimistic message for foot problems in diabetes. West J Med. 1993 Jan; 158(1):78-9.
    View in: PubMed
  122. Young MJ, Veves A, Walker MG, Boulton AJ. Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy? Diabetologia. 1992 Dec; 35(12):1146-50.
    View in: PubMed
  123. Veves A, Boulton AJ. Measuring subjective symptoms. Diabetes Care. 1992 Oct; 15(10):1434.
    View in: PubMed
  124. Malik RA, Veves A, Masson EA, Sharma AK, Ah-See AK, Schady W, Lye RH, Boulton AJ. Endoneurial capillary abnormalities in mild human diabetic neuropathy. J Neurol Neurosurg Psychiatry. 1992 Jul; 55(7):557-61.
    View in: PubMed
  125. Veves A, Murray HJ, Young MJ, Boulton AJ. The risk of foot ulceration in diabetic patients with high foot pressure: a prospective study. Diabetologia. 1992 Jul; 35(7):660-3.
    View in: PubMed
  126. Veves A, Van Ross ER, Boulton AJ. Foot pressure measurements in diabetic and nondiabetic amputees. Diabetes Care. 1992 Jul; 15(7):905-7.
    View in: PubMed
  127. Veves A, Malik RA, Lye RH, Masson EA, Sharma AK, Schady W, Boulton AJ. The relationship between sural nerve morphometric findings and measures of peripheral nerve function in mild diabetic neuropathy. Diabet Med. 1991 Dec; 8(10):917-21.
    View in: PubMed
  128. Dent MT, Veves A, Tebbs SE, Gonzalez AM, Malik RA, Boulton AJ, Ward JD, Wilson RM. Neutrophil aldose reductase activity as a potential marker for neuropathy and cataract in diabetes. Diabet Med. 1991 Dec; 8(10):911-6.
    View in: PubMed
  129. Kumar S, Fernando DJ, Veves A, Knowles EA, Young MJ, Boulton AJ. Semmes-Weinstein monofilaments: a simple, effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Diabetes Res Clin Pract. 1991 Aug; 13(1-2):63-7.
    View in: PubMed
  130. Fernando DJ, Hutchison A, Veves A, Gokal R, Boulton AJ. Risk factors for non-ischaemic foot ulceration in diabetic nephropathy. Diabet Med. 1991 Apr; 8(3):223-5.
    View in: PubMed
  131. Fernando DJ, Masson EA, Veves A, Boulton AJ. Relationship of limited joint mobility to abnormal foot pressures and diabetic foot ulceration. Diabetes Care. 1991 Jan; 14(1):8-11.
    View in: PubMed
  132. Veves A, Masson EA, Fernando DJ, Boulton AJ. Studies of experimental hosiery in diabetic neuropathic patients with high foot pressures. Diabet Med. 1990 May; 7(4):324-6.
    View in: PubMed
  133. Veves A, Masson EA, Fernando DJ, Boulton AJ. Use of experimental padded hosiery to reduce abnormal foot pressures in diabetic neuropathy. Diabetes Care. 1989 Oct; 12(9):653-5.
    View in: PubMed
  134. Masson EA, Veves A, Fernando D, Boulton AJ. Current perception thresholds: a new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia. 1989 Oct; 32(10):724-8.
    View in: PubMed
  135. Masson EA, Hay EM, Stockley I, Veves A, Betts RP, Boulton AJ. Abnormal foot pressures alone may not cause ulceration. Diabet Med. 1989 Jul; 6(5):426-8.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Veves's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_